Increased access to liver transplantation for patients with acute on chronic liver failure after implementation of Share 35 Rule: An analysis from the UNOS database

Arroyo, 2015, Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis, J Hepatol, 62, S131, 10.1016/j.jhep.2014.11.045 Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 Bajaj, 2018, Acute-on-chronic liver failure: getting ready for prime time?, Hepatology, 68, 1621, 10.1002/hep.30056 Gustot, 2015, Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis, Hepatology, 62, 243, 10.1002/hep.27849 O’Leary, 2018, NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis, Hepatology, 67, 2367, 10.1002/hep.29773 Allen, 2016, Time trends in the health care burden and mortality of acute on chronic liver failure in the United States, Hepatology, 64, 2165, 10.1002/hep.28812 Artru, 2017, Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3, J Hepatol, 67, 708, 10.1016/j.jhep.2017.06.009 Jalan, 2014, Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure, J Hepatol, 61, 1038, 10.1016/j.jhep.2014.06.012 Thuluvath, 2018, Liver transplantation in patients with multiple organ failures: feasibility and outcomes, J Hepatol, 69, 1047, 10.1016/j.jhep.2018.07.007 Sundaram, 2019, Patients with acute on chronic liver failure grade 3 have greater 14-day waitlist mortality than status-1a patients, Hepatology, 70, 334, 10.1002/hep.30624 Sharma, 2012, End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates, Hepatology, 55, 192, 10.1002/hep.24632 Pomfret, 2010, Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States, Liver Transpl, 16, 262, 10.1002/lt.21999 Goldberg, 2012, Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma, Liver Transpl, 18, 434, 10.1002/lt.23394 Massie, 2011, MELD exceptions and rates of waiting list outcomes, Am J Transplant, 11, 2362, 10.1111/j.1600-6143.2011.03735.x Edwards, 2016, The impact of broader regional sharing of livers: 2-year results of “Share 35”, Liver Transpl, 22, 399, 10.1002/lt.24418 Kwong, 2018, Improved posttransplant mortality after share 35 for liver transplantation, Hepatology, 67, 273, 10.1002/hep.29301 Croome, 2017, Effects of the Share 35 Rule on waitlist and liver transplantation outcomes for patients with hepatocellular carcinoma, PLOS ONE, 12, e0170673, 10.1371/journal.pone.0170673 Mahmud, 2019, Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis, Hepatology, 69, 2150, 10.1002/hep.30494 Leao, 2019, Acute-on-chronic liver failure: a comparison of three different diagnostic criteria, Ann Hepatol, 18, 373, 10.1016/j.aohep.2019.01.001 Cardoso, 2018, Acute-on-chronic liver failure defined by NACSELD: the impact on prognosis and futility of care, Hepatology, 68, 2046, 10.1002/hep.30265 Reuter, 2018, Assessment of the spectrum of hepatic encephalopathy: a multicenter study, Liver Transpl, 24, 587, 10.1002/lt.25032